Administration form for the oral application of 3-(2-{4-(hexyloxycarbonyl-amino-imino-methyl)-phenylamino-methyl}-1-methyl-1 H-benzimidazol acid ethyl ester and the salts thereof

摘要

The invention relates to a new administration form for the oral application of the active substance ethyl 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazole-5-carbonyl)-pyridin-2-yl-amino]-propionate and the pharmacologically acceptable salts thereof.